Drug costs in context: assessing drug costs in cost-of-illness analyses

T Joseph Mattingly II, Shannon Weathers

Article Type

Commentary

Published

This article aims to provide contextual information for a general audience interested in conducting or evaluating cost-of-illness studies that may include drug costs and to describe key factors to consider when reviewing drug costs in the peer-reviewed literature.

Read more

Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

Steven H Abman, Nicholas R Fox, M Ibrahim Malik, Sneha S Kelkar, Shelby L Corman, Sanika Rege, Jenna Bhaloo, Rachel Shah, Ren-Jay Shei, Dana Saporito, Nisreen Shamseddine, Erik DeBoer, George J Wan, on behalf of the NOTICE Study Investigators

Article Type

Original Research

Published

This article aims to describe real-world inhaled nitric oxide use and outcomes in patients with COVID-19 with mild-to-moderate acute respiratory distress syndrome in the United States.

Read more

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis

Howard Busch, George J Wan, John Niewoehner, Parul Houston, Yujie Su, Cassie Clinton, Mary P Panaccio

Article Type

Original Research

Published

This study aims to describe real-world use and outcomes of patients with rheumatoid arthritis prescribed repository corticotropin injection in clinical practice through retrospective analysis of an electronic medical record database.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.